P16-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for P16-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new P16-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for P16-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test guides safer cancer treatment after surgery
Disease control Recruiting nowThis study tests whether a blood test that detects tumor DNA can help doctors choose the right amount of chemotherapy and radiation after surgery for HPV-positive throat cancer. The goal is to give less intense treatment to patients with a low risk of cancer returning, reducing s…
Matched conditions: P16-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Zachary Zumsteg • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis study is for people with HPV-positive oropharyngeal (throat) cancer who have had surgery. Researchers want to see if giving a lower dose of radiation to a smaller area (just the neck, not the original tumor site) works as well as the standard higher dose. The goal is to redu…
Matched conditions: P16-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC